Scope and Structure. 5 2.1. General................................................. 6 2.2. Relationship of TKT and MMD............................. 6 2.3. Commercialization of *******************................ 6 2.3.1. **************************************** Collaborations Prior to the ******* Anniversary of this Agreement........
Appears in 2 contracts
Sources: License Agreement (Transkaryotic Therapies Inc), License Agreement (Transkaryotic Therapies Inc)
Scope and Structure. 5 6 2.1. General................................................. ...................................................... 6 2.2. Relationship of TKT and MMD............................. .................................. 6 2.3. Commercialization of *******************................ ..................... 6 2.3.1. **********************************Exclusive Rights to ****** Collaborations Prior to the ****** Anniversary of this Agreement...................... 6 2.3.2. ****** Collaborations After the ****** Anniversary and Prior to the ***** Anniversary of this Agreement.............................. 6 2.3.3. ****** Collaborations Following the ***** Anniversary of this Agreement................ 7 2.3.4. Payments........................................... 7 2.3.5.
Appears in 2 contracts
Sources: License Agreement (Transkaryotic Therapies Inc), License Agreement (Transkaryotic Therapies Inc)